Literature DB >> 22696023

Oophorectomy for fertility preservation via reduced-port laparoscopic surgery.

Iwaho Kikuchi1, Noriko Kagawa, Sherman Silber, Masashige Kuwayama, Yuji Takehara, Fumihito Aono, Jun Kumakiri, Osamu Kato, Satoru Takeda.   

Abstract

BACKGROUND: For fertility preservation of women patients scheduled to undergo chemotherapy or radiotherapy, unilateral oophorectomy was performed, and the ovary was cryopreserved.
METHODS: Two-port surgery was conducted in 3 patients, and single-port surgery using a single-incision laparoscopic surgery port in 3. An 18-G Cathelin needle equipped with a syringe was directly inserted transabdominally to reach the small follicle on the ovarian surface; then, follicular fluid was recovered by aspiration through the syringe as with in vitro fertilization procedures, and immature oocytes were collected from the resulting culture medium under microscopy and cryopreserved. Vitrification of the ovarian tissue was performed using the cryotissue method.
RESULTS: The operative time and estimated blood loss were 39.7 minutes (17-57) and 8.6 mL (2-20), and the numbers of ovarian cortical tissues and immature oocytes collected were 10.1 (5.5-15) and 16.3 (0-36), respectively.
CONCLUSIONS: It is suggested that fertility preservation operations before chemotherapy or radiotherapy can be safely done using reduced-port surgery.

Entities:  

Keywords:  2 port; SILS; cryopreservation; fertility preservation; laparoscopy; reduced-port surgery (RPS); vitrification

Mesh:

Year:  2012        PMID: 22696023     DOI: 10.1177/1553350612449074

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  4 in total

Review 1.  A review of reported surgical techniques in fertility preservation for prepubertal and adolescent females facing a fertility threatening diagnosis or treatment.

Authors:  Kristine S Corkum; Monica M Laronda; Erin E Rowell
Journal:  Am J Surg       Date:  2017-06-23       Impact factor: 2.565

2.  Comparison between slow freezing and vitrification of ovarian tissue cryopreservation in assigned female at birth transgender people receiving testosterone therapy: data on histological and viability parameters.

Authors:  Aina Borrás; Dolors Manau; Francesc Fabregues; Sara Peralta; Josep Maria Calafell; Gemma Casals; Adela Saco; Inés Agustí; Francisco Carmona
Journal:  J Assist Reprod Genet       Date:  2022-01-31       Impact factor: 3.412

3.  A Systematic Review of Ovarian Tissue Transplantation Outcomes by Ovarian Tissue Processing Size for Cryopreservation.

Authors:  Ashley A Diaz; Hana Kubo; Nicole Handa; Maria Hanna; Monica M Laronda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

4.  The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment.

Authors:  Seido Takae; Yodo Sugishita; Nobuhito Yoshioka; Mariko Hoshina; Yuki Horage; Yorino Sato; Chie Nishijima; Kazuhiro Kawamura; Nao Suzuki
Journal:  J Assist Reprod Genet       Date:  2014-12-03       Impact factor: 3.412

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.